The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.
Changes in the emotional background make significant contributions to the clinical picture of multiple sclerosis (MS), seriously reducing patients' quality of life and hindering adaptation during the process of rehabilitation. The relationship between mental state and disease activity has been discussed in the world literature in recent years and the opinion that mental disorders in MS are pathogenetically based is increasingly widespread. The present article discusses the potential role of substances mediating immune responses-cytokines-in the effects of changes in the functional activity of the nervous system and psychoemotional status. The question of their likely involvement in the pathogenesis of the side effects of immunomodulatory therapy of MS with beta-interferons and glatiramer acetate is discussed.
Spirin
N N
NN
State Educational Institution of Higher Professional Education Yaroslavl Medical Academy, Russian Ministry of Health, Yaroslavl, Russia.
Kasatkin
D S
DS
D016207:Cytokines / Q000502:physiology*; D000068717:Glatiramer Acetate; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D001523:Mental Disorders / Q000139:chemically induced; D009103:Multiple Sclerosis / Q000276:immunology / Q000523:psychology*; D010455:Peptides / Q000009:adverse effects / Q000627:therapeutic use
D016207:Cytokines; D010455:Peptides; D000068717:Glatiramer Acetate; D007372:Interferons